Comparative Study on the Antidiabetic Efficacy of Unripe and Ripe Fruit Extracts of Siraitia grosvenorii and the Possible Mechanism of Action
European Journal of Medicinal Plants,
Aims: The ripe fruit of Siraitia grosvenorii (Swingle) C. Jeffrey (Cucurbitaceae) is used in Traditional Chinese Medicine (TCM) for treatment of diabetes. The ripe fruit is very edible, nutritious and of high sweet taste, while the unripe fruit which is usually very bitter and not edible, has not been widely studied. Therefore, the aim of this study is to evaluate the antidiabetic activity of the unripe fruit of S. grosvenorii and to compare it with that of the ripe fruit as well as to determine their possible mechanism of action.
Methodology: The method of streptozotocin-nicotinamide induced diabetic animal model in mice was employed and mice with blood glucose greater than 9.0 mmol/l were selected for treatment with unripe fruit extract (UFE) and ripe fruit extract (RFE) for 24 days. Alpha-glucosidase and alpha amylase enzymes inhibitory assays for determination of possible mechanism of action, were performed.
Results: The RFE exhibited better efficacy in antidiabetic activity than the UFE, though the later displayed better potency in activity. The RFE, UFE (300 mg/kg) and glibenclamide exhibited significant (P<0.05) percentage blood glucose reduction (PBGR) of 67.04, 60.69 and 62.88%, respectively, in diabetic mice. Alpha glucosidase assay showed median inhibitory concentration (IC50) value of 7.60 and 6.62 mg/ml for RFE and UFE, respectively, while the alpha amylase inhibitory assay exhibited percentage inhibition of 84.78 and 95.10% for RFE and UFE (25 mg/ml), respectively.
Conclusion: The ripe and unripe extracts of S. grosvenorii exhibited antidiabetic activities, and RFE proved a better efficacious activity than UFE, which showed more potent activity. In addition, the antidiabetic activity is likely being mediated through alpha glucosidase and alpha amylase enzymes inhibition.
- Siraitia grosvenorii fruit
- alpha glucosidase.
How to Cite
Akunne TC, Ilogu LC, Obi BC, Akah PA. Protective effects of Buchholzia coriacea seeds extract and fractions on blood glucose and hyperlipidemia in diabetic rats. Int. J. Basic & Clin. Pharmacol. 2017;6(8): 1856-1864.
Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523.
Wang L, Yang Z, Lu F, Liu J, Song Y, Li D. Cucurbitane glycosides derived from mogroside IIE: Structure-taste relationship, antioxidant and acute toxicity. Molecules. 2014;19:12676-12689.
Wang R, Chiu CH, Lu TJ, Lo YC. Bio transformation of mogrosides. In: Merillon JM, Ramawat KG, Editors. Sweeteners Reference Series in Phytochemistry. Springer: Cham. 2017;1-13.
Suzuki YA, Murata Y, Inui H, Sugiura M, Nakano Y. Triterpene glycosides of Siraitia grosvenori inhibit rat intestinal maltase and suppress the rise in blood glucose level after a single oral administration of maltose in rats. J. Agric. Food. Chem. 2005;53: 2941-2946.
LiF, Yang F, Liu X, Wang L, Chen B, Li L, Wang M. Cucurbitane glycosides from the fruit of Siraitia grosvenorii and their effects on glucose uptake in human HepG2 cells In vitro. Food Chem. 2017;228:567-573.
Li D, Ikedia T, Nohara T, Liu J, Wen Y, Sakamoto T, Nonaka GI. Cucurbitane glycosides from unripe fruits of Siraitia grosvenorii. Chem. Pharm. Bull. 2007; 55(7):1082-1086.
Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol. 2015;70:5.47.1-5.47.20. DOI:10.1002/0471141755.ph054s70
Apostolidis E, Kwon YI, Shetty K. Inhibitory potential of herb, fruit, and fungal enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Inn Food Sci Emer Technol. 2007;8:46–54.
Subramanian R, Asmawi MZ, Sadikun A. In vitro α-glucosidase and α-amylase enzyme inhibitory effects of Andrographis paniculate extract and andrographolide. Acta Biochim. Pol. 2008;55(2):391-398.
Chun L, Li-Mei L, Feng S,Zhi-Min W, Hai-Ru H, Li D, Ting-Liang J. Chemistry and pharmacology of Siraitia grosvenorii: A review. Chin J Nat Med. 2014;12(2):89-102.
Maduwanthi SDT, Marapana RA. Induced ripening agents and their effect on fruit quality of Banana. Int. J. Food Sci. 2019;8. [Article ID 2520179]
Jin JS, Lee JH. Phytochemical and pharmacological aspects of Siraitia grosvenorii, luohankuo. Orient Pharm Exp Med. 2012;12:233-239.
Andrade-Cetto A, Becerra-Jimenez J, Cardenas-Vazquez R. Alfa-glucosidase-inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes. J. Ethnopharmcol. 2008;116:27-32.
Fenglai L, Xiaojie Y, Xiangli X, Akunne TC, Dianpeng L. Phytochemicals from Siraitia grosvenorii: New minor compounds and advances in pharmacological activities. EC Pharmacol Toxicol., 2019;7(3):195-204.
Chipiti T, Ibrahim MA, Singh M, Islam M. In vitro α-amylase and α-glucosidase inhibitory and cytotoxic activities of extracts from Cissuscornifolia Plant Parts, Phcog Mag. 2017;13,Suppl S2:329-333.
Ezeani C, Ezenyi IC, Okoye TC, Okoli CO. Ocimum basilicum extract exhibits antidiabetic effects via inhibition of hepatic glucose mobilization and carbohydrate metabolizing enzymes. J. Intercult. Ethnopharmacol. 2017;6(1):22-28.
Yetendje LC, Njateng GSS, Dongmo AA, Mouokeu RS, Feudjio C, Tamekou SL, Iqbal J. In vivo antidiabetic activity and mechanism of action of three Cameroonian medicinal plant extracts. Int. J. Res. –Granthaalayah. 2019;7(8):415-430.
Priya RM, Padmakumari KP. In vitro studies to assess the antidiabetic, antiperoxidative, and radical scavenging potential of Stereospermum colais, Pharm. Biol. 2012;50(10):1254-1260.
Abstract View: 1100 times
PDF Download: 492 times